Tezepelumab Phase 1 PK Study in Healthy Chinese Subjects

Clinical trial NCT04362410 · COMPLETED

Trial details

NCT number: NCT04362410
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2020-05-18
Primary completion: 2020-10-09
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.